Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.796 USD | +0.39% | -40.24% | -29.04% |
05-15 | Top Midday Decliners | MT |
05-15 | Bolt Biotherapeutics Stops Development of Trastuzumab Imbotolimod, Cuts Workforce by 50% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.04% | 30.23M | |
+9.85% | 115B | |
+12.01% | 106B | |
-2.82% | 21.96B | |
-13.69% | 21.87B | |
-5.29% | 19.21B | |
-3.72% | 18.08B | |
-38.57% | 17.71B | |
+6.49% | 14.32B | |
+34.54% | 12.42B |
- Stock Market
- Equities
- BOLT Stock
- News Bolt Biotherapeutics, Inc.
- Stifel Adjusts Bolt Biotherapeutics' Price Target to $19 From $34, Reiterates Buy Rating